Audrey Lau

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto et al. · Journal of Hepatology · 2018 · 406 citations · Full text

Hepatology, Viral Hepatitis, Pharmacology +10

Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B

Harry L.A. Janssen, Maurizia Rossana Brunetto, Yoon Jun Kim et al. · Journal of Hepatology · 2017 · 191 citations · Full text

Hepatitis D, Hepatology, Autoimmune Disease +14

Low TLR4 Expression by Liver Dendritic Cells Correlates with Reduced Capacity to Activate Allogeneic T Cells in Response to Endotoxin

An De Creus, Masanori Abe, Audrey Lau et al. · The Journal of Immunology · 2005 · 156 citations · Full text

TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues

Carolina Boni, Andrea Vecchi, Marzia Rossi et al. · Gastroenterology · 2018 · 142 citations

Natural Killer Cells, Ide Analogues, Viral Hepatitis +11

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

Pietro Lampertico, Scott Fung, Sang Hoon Ahn et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 139 citations

Hepatology, Viral Hepatitis, Pharmacology +8